Clarity Pharmaceuticals Ltd.ASX: CU6

Ceasing to be a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX ·

605 Page 1 24-Sep-2026To Company Name/SchemeACN/ARSN1. Details of substantial holder (1)NameACN/ARSN (if applicable)The holder ceased to be a substantial holder on22/09/2026The previous notice was given to the company on22/09/2026The previous notice was dated18/09/20262. Changes in relevant...

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases